A comparative clinico-experimental evaluation of Rasayana Drugs administered orally & by Basti in the management of Madhumeha w. s. r. to Type-II Diabetes Mellitus

Phase 2

Completed

• Conditions: Health Condition 1: null- Type 2 Diabetes Mellitus

• Registration Number: CTRI/2013/05/003705
• Lead Sponsor: Institute for post graduate teaching and research in Ayurveda Gujarat Ayurved University Jamnagar

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 100

Inclusion Criteria

Patient of NIDDM with blood sugar level,

FBS- 126 to 220 mg/dl or

PPBS- 180 to 300 mg/dl.

Exclusion Criteria

Patients having age less than 20 years & above 60 years.

Patients of Type-I Diabetes or the patients of Type-II Diabetes taking Insulin.

Patients having complications of Diabetes like Nephropathy, Retinopathy, Diabetic Foot, Carbuncles etc.

Patients having Diabetes in association with other endocrinopathies like Phaeochromocytoma, Acromegaly, Cushingâ??s syndrome, hyperthyroidism etc.

Patients having drug or chemical induced Type II Diabetes, like glucocorticoids induced or thyroid hormone induced etc.

Patients with genetic syndromes associated with Type II Diabetes like Downâ??s Syndrome, Klinefelterâ??s Syndrome, Turnerâ??s Syndrome etc.

Patients complicated with any Cardiovascular diseases, Renal diseases, Carcinoma or any other disease effecting multiple body systems and pregnant women etc.

Patients contraindicated for Bastikarma as per classics

Study & Design

• Study Type: Interventional
• Study Design: Not specified